Stock Markets July 6, 2026 07:51 AM

Csquare Files for NYSE IPO, Seeks Up to $1.55 Billion in Gross Proceeds

Company to offer 50 million shares with a $23.00 to $27.00 per-share range; underwriters include Morgan Stanley and TD Securities

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn

Csquare, Inc. has launched an initial public offering of 50,000,000 common shares with an expected price range of $23.00 to $27.00 per share. The company estimates gross proceeds between $1.15 billion and $1.35 billion before underwriting discounts and commissions, rising to as much as $1.32 billion to $1.55 billion if the underwriters fully exercise a 30-day over-allotment option for an additional 7,500,000 shares. Shares are expected to trade on the New York Stock Exchange under the ticker CSQR. Proceeds will be used to repay outstanding indebtedness, pay offering-related fees and expenses, and for general corporate purposes. The offering is led by Morgan Stanley and TD Securities, with a syndicate of joint book-runners and co-managers.

Csquare Files for NYSE IPO, Seeks Up to $1.55 Billion in Gross Proceeds
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Csquare is offering 50,000,000 common shares with an expected price range of $23.00 to $27.00 per share; gross proceeds are estimated at $1.15 billion to $1.35 billion before underwriting discounts and commissions.
  • Underwriters have a 30-day option to buy up to 7,500,000 additional shares at the IPO price; full exercise would increase gross proceeds to approximately $1.32 billion to $1.55 billion. Sectors impacted include financial services and capital markets due to underwriting and listing activity.
  • Proceeds will be used to repay outstanding indebtedness, to cover offering fees and expenses, and for general corporate purposes; the shares are expected to trade on the NYSE under the ticker CSQR.

Csquare, Inc. announced the start of an initial public offering for 50,000,000 shares of its common stock, with the company setting an anticipated price band of $23.00 to $27.00 per share. The filing states that, before underwriting discounts and commissions, the offering is expected to generate gross proceeds in the range of approximately $1.15 billion to $1.35 billion.

The company has also provided details on the potential extension of proceeds via the underwriters' over-allotment option. If that option is exercised in full, which would entail the purchase of up to an additional 7,500,000 shares at the initial public offering price within a 30-day window, total gross proceeds could rise to an estimated $1.32 billion to $1.55 billion.

Csquare anticipates listing its common stock on the New York Stock Exchange under the symbol CSQR. In its statement, the company indicated it intends to allocate a portion of the net proceeds to repay outstanding indebtedness and to cover fees and expenses associated with the offering. Any remaining proceeds are planned to be used for general corporate purposes.

The underwriting group is being led by Morgan Stanley and TD Securities, who serve as representatives of the syndicate. The filing lists joint lead book-running managers as Morgan Stanley, TD Securities, Wells Fargo Securities, BofA Securities, BMO Capital Markets, and Scotiabank. In addition, Jefferies, J.P. Morgan, RBC Capital Markets, and Societe Generale are named as joint book-running managers. Brookfield Capital Solutions, CIBC Capital Markets, National Bank of Canada Capital Markets, and PNC Capital Markets LLC are listed as co-managers.

The company did not provide additional operational or financial details in the announcement beyond the offering structure, expected pricing range, use of proceeds, and the names of the underwriting parties. The timing of when shares will begin trading was not specified beyond the expectation that they will trade on the NYSE under the ticker CSQR.


Clear summary

Csquare has launched an IPO of 50,000,000 common shares with a $23.00 to $27.00 per-share expected range, aiming to raise approximately $1.15 billion to $1.35 billion in gross proceeds before underwriting discounts and commissions. An over-allotment option of 7,500,000 shares could lift potential proceeds to about $1.32 billion to $1.55 billion. The company plans to trade on the New York Stock Exchange as CSQR and will use proceeds to repay debt, pay offering costs, and for general corporate purposes. The offering is led by Morgan Stanley and TD Securities with a syndicate of joint book-runners and co-managers.

Risks

  • Price uncertainty inherent in the $23.00 to $27.00 expected range - market conditions at pricing could affect the final offer price and investor demand, impacting proceeds. This primarily affects equity markets and investor allocation decisions.
  • The potential increase in proceeds depends on underwriters exercising their 30-day over-allotment option for up to 7,500,000 additional shares; there is no guarantee this option will be exercised, which could reduce total capital raised and influence the capital structure.
  • A portion of proceeds is earmarked to repay outstanding indebtedness; the effectiveness of debt repayment on the company’s financial position will depend on the final amount raised and is tied to corporate finance and credit market outcomes.

More from Stock Markets

Orthofix Rally Follows Medicare Reversal on Bone Growth Stimulator Payments Jul 6, 2026 Wolfe trims Microsoft price target as memory-driven capex outlook rises Jul 6, 2026 Microsoft to Cut About 4,800 Jobs as It Reallocates Talent to Priority Areas Jul 6, 2026 Bernstein: Sky’s Acquisition Values ITV’s M&E Unit at 5.7x-6.5x EBITA, Contingent Consideration Seen as Unlikely to Reach Cap Jul 6, 2026 Fincantieri snaps up four subsea tech firms in €600 million deal Jul 6, 2026